GlaxoSmithKline’s Volibris (ambrisentan) Receives Authorisation From The European Commission For The Treatment Of Functional Class Hypertension

GlaxoSmithKline (GSK) announced that the European Commission has issued marketing authorisation for Volibris� (ambrisentan) for the treatment of Pulmonary Arterial Hypertension (PAH) in patients classified as World Health Organisation (WHO) Functional Class II and III, to improve exercise capacity.1 Efficacy has been shown in idiopathic PAH (IPAH) and in PAH associated with connective tissue disease.

More: continued here

Filed under: Hypertension on May 15th, 2008

Comments are closed.

« Asthma Attacks Early In Pregnancy Put Baby At Greater Risk Of Birth Defects, New Research Suggests Immune System Pathway Identified To Fight Allergens, Asthma »

Fioricet Supply - Buy Online: Fioricet is used to treat tension headaches.
Healthy Recipes 4 All - : Healthy Recipes 4 All
My RX Pharmacy - Buy Online: My RX pharmacy
Online RX Store - Buy Drugs: Store for Rx products
Order pills online - : Order pills online
Pay Less for Generic - : Pay Less for Generic
Pharmacy Brand Name - Buy Brandname Drugs: Depending on your prescription needs, your savings could be significant if you order online.
Reliable Prescriptions Online - : Reliable Prescriptions Online
Yo Durgs - Buy Your Pills: Getting drugs online gives you many advantages like privacy, saving money and saving TIME
My super dtrug store - : My super dtrug store
Latest News...